Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials

Fig. 1

Ceramide distribution at different time points. Boxplots of ceramides before and after liraglutide and placebo in (A) LirAlbu12 and (B) LiraFlame26. Line graphs of C16 Cer amount per week over the two trials, modeled as linear mixed models: Ceramide ~ Treatment + Time + Treatment:Time + (1|Participant ID), for (C) LirAlbu12 and (D) LiraFlame26. The ceramide amount was measured as the ratio of ceramide intensity divided by the intensity of pure standard (peak area of ceramide / peak area ceramide standard)

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X